Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Acquired by American Century Companies Inc.

American Century Companies Inc. boosted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 99.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 9,444 shares of the medical instruments supplier's stock after acquiring an additional 4,698 shares during the quarter. American Century Companies Inc. owned 0.17% of Mesa Laboratories worth $1,245,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Mesa Laboratories by 20.3% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 10,103 shares of the medical instruments supplier's stock valued at $1,312,000 after buying an additional 1,708 shares during the last quarter. Barclays PLC lifted its stake in Mesa Laboratories by 357.4% in the 3rd quarter. Barclays PLC now owns 8,837 shares of the medical instruments supplier's stock worth $1,148,000 after purchasing an additional 6,905 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Mesa Laboratories by 4.8% during the 3rd quarter. Geode Capital Management LLC now owns 124,761 shares of the medical instruments supplier's stock worth $16,205,000 after purchasing an additional 5,771 shares during the last quarter. Franklin Resources Inc. grew its position in shares of Mesa Laboratories by 27.8% in the third quarter. Franklin Resources Inc. now owns 6,444 shares of the medical instruments supplier's stock valued at $828,000 after purchasing an additional 1,403 shares in the last quarter. Finally, Principal Financial Group Inc. increased its holdings in shares of Mesa Laboratories by 21.8% in the third quarter. Principal Financial Group Inc. now owns 35,107 shares of the medical instruments supplier's stock valued at $4,559,000 after purchasing an additional 6,292 shares during the last quarter. 90.60% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Mesa Laboratories Trading Down 0.9 %

NASDAQ:MLAB traded down $1.08 during trading hours on Tuesday, hitting $113.01. The company had a trading volume of 25,900 shares, compared to its average volume of 38,764. Mesa Laboratories, Inc. has a 1 year low of $83.68 and a 1 year high of $155.12. The company has a market cap of $614.10 million, a P/E ratio of -2.44 and a beta of 0.92. The company has a 50-day moving average of $129.73 and a 200 day moving average of $128.11. The company has a current ratio of 0.71, a quick ratio of 0.53 and a debt-to-equity ratio of 0.61.

Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last issued its earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 EPS for the quarter, topping analysts' consensus estimates of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. Sell-side analysts expect that Mesa Laboratories, Inc. will post 8 earnings per share for the current year.

Mesa Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 30th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, May 30th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.57%. Mesa Laboratories's payout ratio is currently -1.38%.

Insider Activity at Mesa Laboratories

In other news, CEO Gary M. Owens sold 21,000 shares of Mesa Laboratories stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total value of $2,602,110.00. Following the completion of the sale, the chief executive officer now directly owns 43,337 shares of the company's stock, valued at approximately $5,369,887.67. The trade was a 32.64 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 4.40% of the stock is owned by insiders.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.